• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者中Ki-67(MIB-1)和P53表达的频率。

Frequency of Ki-67 (MIB-1) and P53 expressions among patients with prostate cancer.

作者信息

Madani Seyed Hamid, Ameli Somayeh, Khazaei Sedigheh, Kanani Malek, Izadi Babak

机构信息

Molecular Pathology Research Center, Emam Reza Hospital, Kermanshah University of Medical sciences, Kermanshah, Iran.

出版信息

Indian J Pathol Microbiol. 2011 Oct-Dec;54(4):688-91. doi: 10.4103/0377-4929.91492.

DOI:10.4103/0377-4929.91492
PMID:22234091
Abstract

CONTEXT

Prostate cancer is the most common malignant tumor in men. Tumor grade is one of the most important prognostic factors of prostate cancer. P53 and Ki-67 expressions have also been considered to be prognostic factors.

AIMS

This study was performed to investigate the frequency of these proteins expression and compare the obtained results with Gleason's grading.

SETTINGS AND DESIGN

In this cross-sectional study, 49 paraffin blocks of prostate cancers were assessed. Tumor grade was determined according to the Gleason's criteria.

MATERIALS AND METHODS

Ki-67 and P53 expressions were determined by immunohistochemical staining.

STATISTICAL ANALYSIS

The obtained results were analyzed and evaluated using Spearman's statistical test (SPSS version 15).

RESULTS

Three out of 49 (6.1%) cases were well differentiated, 21 (43%) moderately differentiated and 25 (51%) were poorly differentiated. P53 was negative in all well-differentiated cases. Ki-67 was negative in 14 cases (28%) including all well-differentiated tumors. Among moderately and poorly differentiated tumors Ki-67 was negative in eight (38%) and three (12%) of cases, respectively. A statistically significant relation was observed between the increased Ki-67 labeling index (LI) and increased Gleason's grade. Conversely, no statistically significant relation was found between P53 expression and increased Gleason's grade.

CONCLUSIONS

According to the findings of this study, it seems that Ki-67 can be used as a prognostic factor for prostate cancer. On the other hand, the probable relation between P-53 and prostate cancer prognosis requires further studies.

摘要

背景

前列腺癌是男性最常见的恶性肿瘤。肿瘤分级是前列腺癌最重要的预后因素之一。P53和Ki-67的表达也被认为是预后因素。

目的

本研究旨在调查这些蛋白质表达的频率,并将所得结果与 Gleason 分级进行比较。

设置与设计

在这项横断面研究中,评估了49个前列腺癌石蜡块。根据 Gleason 标准确定肿瘤分级。

材料与方法

通过免疫组织化学染色确定Ki-67和P53的表达。

统计分析

使用Spearman统计检验(SPSS 15版)对所得结果进行分析和评估。

结果

49例中有3例(6.1%)为高分化,21例(43%)为中分化,25例(51%)为低分化。所有高分化病例中P53均为阴性。Ki-67在14例(28%)中为阴性,包括所有高分化肿瘤。在中分化和低分化肿瘤中,Ki-67分别在8例(38%)和3例(12%)中为阴性。观察到Ki-67标记指数(LI)增加与Gleason分级增加之间存在统计学显著关系。相反,未发现P53表达与Gleason分级增加之间存在统计学显著关系。

结论

根据本研究结果,似乎Ki-67可作为前列腺癌的预后因素。另一方面,P53与前列腺癌预后之间的可能关系需要进一步研究。

相似文献

1
Frequency of Ki-67 (MIB-1) and P53 expressions among patients with prostate cancer.前列腺癌患者中Ki-67(MIB-1)和P53表达的频率。
Indian J Pathol Microbiol. 2011 Oct-Dec;54(4):688-91. doi: 10.4103/0377-4929.91492.
2
Significance of p53 and ki-67 expression in prostate cancer.p53和ki-67在前列腺癌中的表达意义
Urol Ann. 2015 Oct-Dec;7(4):488-93. doi: 10.4103/0974-7796.158507.
3
Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.Ki-67抗原与P53蛋白在前列腺良恶性病变中的表达:免疫组织化学定量研究
Pol J Pathol. 2000;51(1):31-6.
4
The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.口腔鳞状细胞癌中深层浸润前沿的组织学分级与Ki-67抗原和p53蛋白表达的关系。
J Oral Pathol Med. 2005 Nov;34(10):602-7. doi: 10.1111/j.1600-0714.2005.00358.x.
5
Prognostic factors in prostate cancer.前列腺癌的预后因素。
Scand J Urol Nephrol Suppl. 1997;185:1-46.
6
p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.p53蛋白过表达与局部复发性前列腺癌患者放疗后细胞增殖增加有关。
Cancer. 1999 Mar 15;85(6):1293-9.
7
Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.p53、bcl-2和Ki-67在高危浅表性膀胱癌中的预后意义
Anticancer Res. 2002 Nov-Dec;22(6B):3759-64.
8
Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder.Ki-67和p53抗原表达在胆管癌和胆囊癌中的预后意义。
J Med Invest. 1998 Aug;45(1-4):95-102.
9
The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.p53和bcl-2在肺腺癌中的表达的预后意义及其与Ki-67增殖分数的相关性。
Cancer. 1997 Sep 15;80(6):1034-45.
10
[The role of repeated biopsies in prognosis of prostate cancer].
Orv Hetil. 2002 Jul 7;143(27):1619-23.

引用本文的文献

1
A Study of Ki-67 Immunostaining in Prostate Carcinomas and Its Correlation with Gleason's Score and Prognosis: An Experience at a Tertiary Centre in the Himalayan Foothills.前列腺癌中Ki-67免疫染色及其与Gleason评分和预后的相关性研究:喜马拉雅山麓一家三级中心的经验
Indian J Surg Oncol. 2024 Jun;15(2):341-348. doi: 10.1007/s13193-024-01902-4. Epub 2024 Feb 21.
2
Characterization of the Tumor Microenvironment and the Biological Processes with a Role in Prostatic Tumorigenesis.前列腺肿瘤发生过程中肿瘤微环境及相关生物学过程的特征分析
Biomedicines. 2022 Jul 12;10(7):1672. doi: 10.3390/biomedicines10071672.
3
Suppressive Effect and Molecular Mechanism of Thunb. Extract against Prostate Carcinogenesis and Castration-Resistant Prostate Cancer.
白茅提取物对前列腺癌发生及去势抵抗性前列腺癌的抑制作用及分子机制
Cancers (Basel). 2021 Jul 7;13(14):3403. doi: 10.3390/cancers13143403.
4
Intraperitoneal Injection of Graphene Oxide Nanoparticle Accelerates Stem Cell Therapy Effects on Acute Kidney Injury.腹腔注射氧化石墨烯纳米颗粒可加速干细胞疗法对急性肾损伤的治疗效果。
Stem Cells Cloning. 2020 Feb 11;13:21-32. doi: 10.2147/SCCAA.S212087. eCollection 2020.
5
Significance of p53 and ki-67 expression in prostate cancer.p53和ki-67在前列腺癌中的表达意义
Urol Ann. 2015 Oct-Dec;7(4):488-93. doi: 10.4103/0974-7796.158507.
6
Expression of estrogen receptor β and Ki 67 in benign & malignant human prostate lesions by immunohistochemistry.免疫组织化学法检测雌激素受体β和Ki 67在人前列腺良恶性病变中的表达
Pathol Oncol Res. 2015 Jul;21(3):651-7. doi: 10.1007/s12253-014-9870-y. Epub 2014 Dec 20.
7
The effects of phenoxodiol on the cell cycle of prostate cancer cell lines.苯氧二醇对前列腺癌细胞系细胞周期的影响。
Cancer Cell Int. 2014 Nov 8;14(1):110. doi: 10.1186/s12935-014-0110-z. eCollection 2014.
8
Prostate cancer: the need for biomarkers and new therapeutic targets.前列腺癌:生物标志物和新治疗靶点的需求。
J Zhejiang Univ Sci B. 2014 Jan;15(1):16-42. doi: 10.1631/jzus.B1300106.
9
Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.福尔马林固定石蜡包埋组织中前列腺癌的分子标志物
Biomed Res Int. 2013;2013:283635. doi: 10.1155/2013/283635. Epub 2013 Nov 25.
10
Current challenges in development of differentially expressed and prognostic prostate cancer biomarkers.差异表达和预后性前列腺癌生物标志物开发中的当前挑战。
Prostate Cancer. 2012;2012:640968. doi: 10.1155/2012/640968. Epub 2012 Aug 28.